ILIU - Interleukin Genetics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0079
-0.0011 (-12.2222%)
At close: 1:20PM EDT
Stock chart is not supported by your current browser
Previous Close0.0090
Open0.0070
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0070 - 0.0079
52 Week Range0.0040 - 0.2000
Volume18,435
Avg. Volume163,771
Market Cap1.81M
Beta-0.61
PE Ratio (TTM)-0.20
EPS (TTM)-0.04
Earnings DateMar 17, 2017 - Mar 20, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.60
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    Interleukin Genetics Files Form 15

    WALTHAM, Mass., Aug. 14, 2017-- Interleukin Genetics, Inc. today announced it has filed a Form 15 with the Securities and Exchange Commission completing the process of delisting and deregistering its securities ...

  • GlobeNewswire3 months ago

    Interleukin Genetics Files Form 25

    WALTHAM, Mass., Aug. 04, 2017-- Interleukin Genetics, Inc. today announced it has filed a Form 25 with the Securities and Exchange Commission in furtherance of its plan to delist and deregister its securities ...

  • Interleukin Genetics, Inc. :ILIU-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
    Capital Cube11 months ago

    Interleukin Genetics, Inc. :ILIU-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016

    Categories: Yahoo Finance Get free summary analysis Interleukin Genetics, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Interleukin Genetics, Inc. – Psychemedics Corporation, Genomic Health, Inc., RadNet, Inc., Quest Diagnostics Incorporated, Myriad Genetics, Inc. and Trovagene, Inc. (PMD-US, GHDX-US, RDNT-US, DGX-US, MYGN-US and TROV-US) that ... Read more (Read more...)